Showing results (91-100 of 126) with videos related to

Sort By:
Pageof 13
Circulation|November 1, 1988
Short-term hemodynamic effects of vasopressin V1-receptor inhibition in chronic right-sided congestive heart failureC K Stone, C S Liang, N Imai, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 25, 2000
Alterations in cardiac adrenergic terminal function and beta-adrenoceptor density in pacing-induced heart failureH Kawai, A Mohan, J Hagen, et al.
Circulation|September 1, 1993
Cardiac noradrenergic nerve terminal abnormalities in dogs with experimental congestive heart failureY Himura, S Y Felten, M Kashiki, et al.
Circulation Research|July 1, 1981
Dobutamine infusion in conscious dogs with and without acute myocardial infarction. Effects on systemic hemodynamics, myocardial blood flow, and infarct sizeC S Liang, J M Yi, L G Sherman, et al.
Circulation|February 1, 1987
The role of endogenous opioids in congestive heart failure: effects of nalmefene on systemic and regional hemodynamics in dogsC S Liang, N Imai, C K Stone, et al.
Circulation|December 12, 2001
C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillationM K Chung, D O Martin, D Sprecher, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 2000
Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus GroupM P Dubé, D Sprecher, W K Henry, et al.
Circulation|January 1, 1984
Sustained improvement of cardiac function in patients with congestive heart failure after short-term infusion of dobutamineC S Liang, L G Sherman, J U Doherty, et al.
Toxicology and Applied Pharmacology|March 11, 1992
Pregnancy enhances cardiotoxicity of cocaine: role of progesteroneA Sharma, M A Plessinger, D M Sherer, et al.
Development (Cambridge, England)|August 1, 1993
A fourth human MEF2 transcription factor, hMEF2D, is an early marker of the myogenic lineageR E Breitbart, C S Liang, L B Smoot, et al.
Pageof 13